Capricor Therapeutics (CAPR) Other Working Capital Changes (2010 - 2026)
Capricor Therapeutics (CAPR) recorded quarterly Other Working Capital Changes of -$979776.0 in Q1 2026, down 27.56% quarter-over-quarter from -$768086.0 in Q4 2025, and down 1666.22% on a YoY basis from $62556.7 in Q1 2025.
Capricor Therapeutics (CAPR) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Other Working Capital Changes history runs 16 years deep, the most recent figure standing at -$979776.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 1666.22% year-over-year to -$979776.0; the TTM figure through Mar 2026 stood at -$924303.0 (up 15.95% YoY), while the FY2024 annual figure was $511842.0, down 35.05% from the prior year.
- Other Working Capital Changes was -$979776.0 for Q1 2026 at Capricor Therapeutics, down from -$768086.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $30.0 million in Q1 2022 to a low of -$2.1 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged $1.8 million across 5 years, with a median of $240117.0 in 2024.
- The sharpest annual moves came in 2023 and 2026: Other Working Capital Changes surged 431.57% in 2023, then tumbled 1666.22% in 2026.
- A 5-year view of Other Working Capital Changes shows it stood at $576208.0 in 2022, then sank by 462.38% to -$2.1 million in 2023, then soared by 148.77% to $1.0 million in 2024, then tumbled by 175.43% to -$768086.0 in 2025, then retreated by 27.56% to -$979776.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$979776.0 (Q1 2026), -$768086.0 (Q4 2025), and $966329.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -979,776.00 |
| Mar 31, 2026 | -979,776.00 |
| Dec 31, 2025 | -768,086.00 |
| Dec 31, 2025 | -768,086.00 |
| Sep 30, 2025 | 966,329.00 |
| Sep 30, 2025 | 966,329.00 |
| Jun 30, 2025 | -142,770.00 |
| Jun 30, 2025 | -142,770.00 |
| Mar 31, 2025 | -55,473.00 |
| Mar 31, 2025 | -55,473.00 |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 406,361.00 |
| Sep 30, 2024 | 406,361.00 |
| Jun 30, 2024 | 240,117.00 |
| Jun 30, 2024 | 240,117.00 |
| Mar 31, 2024 | 25,550.00 |
| Mar 31, 2024 | 25,550.00 |
| Dec 31, 2023 | -2.09 Mn |
| Dec 31, 2023 | -2.09 Mn |